Search research articles
Contact Us
Filters
Showing results (1-10 of 31) with videos related to
Page
of 4
Sort By:
Managed Care Interface
|
June 26, 2004
Are formularies still relevant?
Pete Penna
Managed Care Interface
|
April 6, 2006
The effect of price changes on utilization
Pete Penna
Managed Care Interface
|
August 11, 2006
Medication therapy management is an opportunity for pharmacy to shine--or fail
Pete Penna
Managed Care Interface
|
June 7, 2003
Rebates and other drug-cost issues
Pete Penna
Managed Care Interface
|
October 5, 2006
The issue of medication adherence raises more questions than answers
Pete Penna
Managed Care Interface
|
June 22, 2006
Managing the triptans
Pete Penna
Managed Care Interface
|
August 12, 2003
The effect of drug reimportation on managed care pharmacy
Pete Penna
Managed Care Interface
|
March 24, 2004
Outcomes research in the Medicare drug benefit
Pete Penna
Managed Care Interface
|
December 3, 2003
Where have we been? How have we done?
Pete Penna
Managed Care Interface
|
September 3, 2004
Patterns of cyclooxygenase-2 inhibitor utilization
Pete Penna
Page
of 4
Search research articles
Search
Showing results (1-10 of 31) with videos related to
Sort By:
Page
of 4
Managed Care Interface
|
June 26, 2004
Are formularies still relevant?
Pete Penna
Managed Care Interface
|
April 6, 2006
The effect of price changes on utilization
Pete Penna
Managed Care Interface
|
August 11, 2006
Medication therapy management is an opportunity for pharmacy to shine--or fail
Pete Penna
Managed Care Interface
|
June 7, 2003
Rebates and other drug-cost issues
Pete Penna
Managed Care Interface
|
October 5, 2006
The issue of medication adherence raises more questions than answers
Pete Penna
Managed Care Interface
|
June 22, 2006
Managing the triptans
Pete Penna
Managed Care Interface
|
August 12, 2003
The effect of drug reimportation on managed care pharmacy
Pete Penna
Managed Care Interface
|
March 24, 2004
Outcomes research in the Medicare drug benefit
Pete Penna
Managed Care Interface
|
December 3, 2003
Where have we been? How have we done?
Pete Penna
Managed Care Interface
|
September 3, 2004
Patterns of cyclooxygenase-2 inhibitor utilization
Pete Penna
Page
of 4